BofA maintains $30 target on Catalyst Pharma following patent deal – Investing.com
BofA maintains $30 target on Catalyst Pharma following patent deal Investing.com
In: PATENT NEWS
BofA maintains $30 target on Catalyst Pharma following patent deal Investing.com
In: PATENT NEWS
Patent Filing Hints at New Brake Mount Innovation From SRAM Bike Magazine
In: TRADEMARK NEWS
Tiger Woods sued by Puma as Sun Day Red faces second trademark lawsuit The Mirror US
In: PATENT NEWS
Hofstra Intellectual Property Law Association (HIPLA) General Meeting. January 29 @ 1:00 pm – 2:00 pm.
In: PATENT NEWS
New USPTO Fee Rule for Continuing Applications: Key Changes and Strategic Considerations for Applicants IPWatchdog.com
In: PATENT NEWS
… patents) and Lupin (only for Catalyst’s FIRDAPSE patent expiring in 2037), is ongoing. As required by law, the companies will submit the …
In: PATENT NEWS
Abbott Beats UC Regents’ Probiotic Patent Claims Law360
In: PATENT NEWS
Nvidia Corp. and Microsoft Corp. said a district judge in Texas should deny a patent-owning plaintiff’s request for venue discovery as the court …
In: PATENT NEWS
Boston Dynamics resolves patent lawsuit with Ghost Robotics Robot Report
In: PATENT NEWS
Nvidia Fights Venue Discovery as It Asks to Transfer Patent Suit Bloomberg Law
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION